Yinfeng Low Temperature Advances to the Southwest - Thousands of Stores in Thousands of Cities and Thousands of Stores Soon
Release time:
2022-09-05
On the morning of September 2, 2022, Shandong Yinfeng Life Science Research Institute and Zhongxing Health Technology Group held a strategic cooperation signing ceremony in Chongqing, and the two sides jointly negotiated and signed a strategic cooperation framework agreement on cryogenic and big health. Liu Zhicheng, head of Yinfeng Cryogenic Medicine, and Hu Guidong, chairman of Zhongxing Health Technology Group, attended the signing ceremony.
At the meeting, the two sides conducted in-depth exchanges on the combination of Yinfeng's life extension plan and general health, drew a development vision, and laid a solid foundation for deepening cooperation in the next step.
Through this strategic cooperation, the two parties look forward to making full use of their own advantages and resources, combining strong forces, so that the scientific and technological achievements of Yinfeng Low Temperature can achieve the ideal effect of "entering the community, entering the family, and everyone knows" through the help of the big health service platform of Zhongxing Health Technology Group, so as to enhance the public's awareness, understanding and participation in Yinfeng's life extension plan, create greater value for the national health cause with practical actions, and help build a healthy China.
Zhongxing Health Technology Group covers health management, chain franchising, hospital holding, industry and finance funds, supply chain, AI intelligence, business schools and other sectors, deeply cultivates chronic diseases, anti-cancer, anti-aging and other health fields, sets up a scientific research team, lays out a "dual-line strategy", and promotes the scale, professionalism and scientific development of the group through the "five fine management" model of precise physical examination, precise prevention, precise treatment, precise rehabilitation and precise management. Now the group has opened branches in Beijing, Chongqing, Xi'an, Xinjiang, Inner Mongolia and other places, the group will be based on strong scientific research strength, with the support of offline chain standardized operation and management, to become a leader in the field of China's big health, and create a new future for China's big health.
Latest developments
The debut and discourse of the YinFeng Life Continuation Project not only served as an authoritative demonstration of its own ethical governance framework but also contributed practical wisdom toward establishing industry norms.
Yinfeng Foundation Honored as "2025 Public Welfare Donor" by Jinan Red Cross
Looking ahead, Yinfeng Foundation will use this recognition as an opportunity to further deepen its strategic collaboration with the Jinan Red Cross, expand cooperation in areas such as life health and emergency response, and continue to empower efforts to accelerate the construction of a "new, strong, excellent, rich, beautiful, and high-quality" modern socialist strong capital city, contributing even more Yinfeng strength to this endeavor.
The team successfully developed the CryoSIM platform, an intelligent microfluidics and deep learning-integrated system. This platform deeply integrates core technologies of deep learning and microfluidics to enable high-throughput, high-precision automated analysis of oocyte membrane permeability. It provides a novel technological tool for optimizing and advancing the clinical translation of oocyte cryopreservation techniques. Additionally, it offers an innovative practical paradigm for the application of artificial intelligence in low-temperature biomedicine and reproductive medicine.
Public Welfare Partnership: A Special Letter from the Jinan Red Cross
On the afternoon of January 30, 2026, the Jinan Red Cross presented a letter of special significance to the Shandong Yinfeng Life Science Public Welfare Foundation (hereinafter referred to as the Yinfeng Foundation).
World’s First Achievement Highlights Brand Leadership
In the future, Yinfeng Life Science Research Institute will continue to uphold its mission of "Dedicated to Medical Technology, Safeguarding Human Health." It will empower brand building with more original and pioneering scientific and technological achievements, contributing wisdom and strength to Shandong's goal of building a national regional innovation hub and promoting Chinese brands on the global stage.
Global First Ovarian Tissue Dual Activation Technology Debuts at 2025 Jinan Achievements Conference
Currently, the ovarian tissue dual activation technology has been successfully applied in clinical practice at Beijing University of Chinese Medicine Shenzhen (Longgang) Hospital, having treated over 400 patients with a treatment success rate of 70%. Over the next three years, Shandong Yinfeng Life Science Research Institute plans to use Jinan as a center to gradually expand the transformation and application of this technological achievement nationwide.
Yinfeng Life Continuation Plan
Address: Yinfeng Biotechnology Park, 1758 Gangyuan 6th Road, High-tech Zone, Jinan City, Shandong Province
Zip Code: 250102
Telephone: 0086-0531-88897351
Mobile: 0086-19953155515
Mobile website
Official WeChat Public Number
Links:Red Cross Society of China丨Shandong Red Cross Society丨Shandong Provincial Health Commission | Yinfeng Group| Yinfeng Biological Group
All rights reserved©Yinfeng Life Continuation Powered by www.300.cn SEO
